drugset / Trial / NCT00791804

Phase II Study of Inhaled AeroLEF for Analgesia After ACL Knee Surgery

NCT00791804 ↗

Phase 2 Completed 19 enrolled YM BioSciences
Non-randomizedSingle-groupOpen-labelTreatment

Summary

To evaluate the safety and efficacy of self-titration to effective analgesia with inhaled AeroLEF in patients with moderate/severe acute pain in the post-surgical setting.

Timeline

Start
2004-02
Primary completion
2004-06
Completion
2004-12

Drugs

EvaluationDrugModalityDoseRoute
Subject AeroLEF Unknown 500 ug/ml Inhaled

Indications

No indication recorded.